Eyetelligence is expanding with the appointment of Babak Asgari as the new Director of Business Development APAC.
Mr Asgari brings over 15 years of medical device experience and global commercial leadership to the Australian-based international company that is developing advanced AI solutions to improve health outcomes.
the company is committed to expanding beyond domestic borders and the appointment of the new Director of Business Development is a step in that direction
In a statement, Eyetelligence said the company is committed to expanding beyond domestic borders and the appointment of the new Director of Business Development is a step in that direction.
“With a steadfast commitment to innovation, we are taking our cutting-edge AI powered eye screening technology to international markets, making advanced healthcare accessible to more patients worldwide” the statement read.
Mr Babak said he was thrilled to be joining the Eyetelligence team.
“The technology we offer is truly amazing and potentially life changing. I believe I could not join at a better time. I am looking forward to the chance to meet everyone at O=MEGA23 and to discussing the opportunity to collaborate and bring cutting edge AI-powered technology to the forefront of healthcare to make a true impact on our patients’ lives,” said Mr Babak.